The study of direct-to-consumer advertising for prescription drugs^☆

References 

1. Federal Register. March 19, 2001, 66, 15494–15495.
2. Food and Drug Administration . Guidance for Industry: Consumer-directed Broadcast Advertisements (Draft Guidance). Rockville, Md: Division of Drug Marketing, Advertising, and Communications (DDMAC); July 1997;62 Federal Register at 43,171
3. Schommer JC, Doucette WR. Consumer Preferences for and Retention of Information from Direct-to-Consumer Advertising. Presented at National Council on Patient Information and Education 12th National Conference, Washington, DC. May 13, 1999.
4. Slaughter E. An Assessment of Consumer Reaction to Direct-to-Consumer Advertising. Presented at American Pharmaceutical Association 146th Annual Meeting, San Antonio, Tex, March 9, 1999.
5. Schommer JC, Doucette WR, Mehta BH. Rote learning after exposure to a direct-to-consumer television advertisement for a prescription drug. Clinical Therapeutics, 20, 617–632.
6. Bero LA, Lipton S. Methods for Studying the Effects of Direct-to-consumer Pharmaceutical Advertising on Health Outcomes and Health Services Utilization. Paper presented at Assessing the Impact of Direct to Consumer (DTC) Advertising on Health Care Use, Costs, and Outcomes: An Examination of Methodological Issues, Opportunities and Strategies, a conference sponsored by the Office of the Assistant Secretary for Planning and Evaluation (ASPE), U.S. Department of Health and Human Services with additional support provided by The Henry J. Kaiser Family Foundation, Washington, DC, May 30, 2001. The Final Post Conference Draft was posted on June 18, 2001 at http://aspe.hhs.gov.
7. Morrison AB, Noll RG. Government and the Regulation of Corporate and Individual Decisions in the Eighties, President's Commission for a National Agenda for the Eighties, A Panel Report. Englewood Cliffs, NJ: Prentice-Hall.
8. Baylor-Henry M. Regulation of prescription drug promotion: direct-to-consumer advertising. Clinical Therapeutics. 1998;20:C86–C95
   • Abstract
   • Full-Text PDF (725 KB)
   • CrossRef
9. Wilkes MS, Bell RA, Kravitz RL. Direct-to-consumer prescription drug advertising: trends, impact, and implications. Health Affairs. 2000;19:110–128
10. Churchill GA. Marketing Research, Methodological Foundations. 6th ed.. New York: The Dryden Press; 1995;
11. Andreasen AR. Backward market research. Harvard Business Review. 1985;63:176
12. O'Dell W, Ruppel AC, Trent RH, Kehoe WJ. Marketing Decision-making: Analytic Framework and Cases. 4th ed.. Cincinnati: South-Western Publishing Company; 1988;
13. Cost Overdose: Growth in Drug Spending for the Elderly, 1999-2010. Washington, DC: Families USA; 2000;
14. Berndt ER. The U.S. pharmaceutical industry: why major growth in times of cost containment?. Health Affairs. 2001;20:100–114
15. Neuman WL. Social Research Methods: Qualitative and Quantitative Approaches. 4th ed.. Boston: Allyn and Bacon; 2000;
16. Gochman DS. Health behavior research. In:  Gochman D editors. Handbook of Health Behavior Research I. New York: Plenum press; 1997;p. 3–20
17. Gochman DS. Personal and social determinants of health behavior. In:  Gochman D editors. Handbook of Health Behavior Research I. New York: Plenum press; 1997;p. 381–400
18. Lau RR. Cognitive representations of health and illness. In:  Gochman D editors. Handbook of Health Behavior Research I. New York: Plenum press; 1997;p. 51–69
19. Strecher VJ, Champion VL, Rosenstock IM. The health belief model and health behavior. In:  Gochman D editors. Handbook of Health Behavior Research I. New York: Plenum press; 1997;p. 71–91
20. Reich JW, Erdal KJ, Zautra AJ. Beliefs about control and health behaviors. In:  Gochman D editors. Handbook of Health Behavior Research I. New York: Plenum press; 1997;p. 93–111
21. Rogers RW, Prentice-Dunn S. Protection motivation theory. In:  Gochman David editors. Handbook of Health Behavior Research I. New York: Plenum press; 1997;p. 113–132
22. Maddux JE, DuCharme KA. Behavioral intentions in theories of health behavior. In:  Gochman D editors. Handbook of Health Behavior Research I. 1997:New York: Plenum press; 1997;p. 133–151
23. Baranowski T. Families and health actions. In:  Gochman D editors. Handbook of Health Behavior Research I. New York: Plenum press; 1997;p. 179–206
24. Tinsley BJ. Maternal influences on children's health behavior. In:  Gochman D editors. Handbook of Health Behavior Research I. New York: Plenum press; 1997;p. 223–240
25. Aday LA, Awe WC. Health services research models. In:  Gochman D editors. Handbook of Health Behavior Research I. New York: Plenum press; 1997;p. 153–172
26. Rogers EM. Diffusion of Innovations. 4th ed.. New York: The Free Press; 1995;
27. Payne JW, Bettman JR, Johnson EJ. The Adaptive Decision Maker. Cambridge: Cambridge University Press; 1993;
28. Chewning BA, Sleath B. Medication decision-making and management: a client-centered model. Social Science and Medicine. 1996;42:389–398
29. Petty RE, Cacioppo JT. Attitudes and Persuasion: Classic and Contemporary Approaches. Dubuque, IA: William C. Brown Company Publishers; 1981;
30. Petty RE, Cacioppo JT. The elaboration likelihood model of persuasion. In:  Berkowitz L editors. Advances in Experimental Social Psychology. vol. 19:New York: Academic Press; 1986;p. 123–205
31. Petty RE, Haugtvedt CP, Smith SM. Elaboration as a determinant of attitude strength: creating attitudes that are persistent, resistant, and predictive of behavior. In:  Petty RE,  Krosnick JA editor. Attitude Strength, Antecedents and Consequences. Mahwah, NJ: Lawrence Erlbaum Associates; 1995;p. 93–130
32. Bettman J. Information processing models of consumer behavior. Journal of Marketing Research. 1970;7:370–376
33. Schommer JC, Doucette WR, Worley MM. Processing prescription drug information under different conditions of presentation. Patient Education and Counseling. 2001;43:49–59
    • Abstract
    • Full Text
    • Full-Text PDF (103 KB)
    • CrossRef
34. Labor SL, Schommer JC, Pathak DS. Information overload with written prescription drug information. Drug Information Journal. 1995;29:1317–1328
    • CrossRef
35. Krugman H. The impact of television advertising: learning without involvement. Public Opinion Quarterly. 1965;11:412–423
    • CrossRef
36. Chaffee SH, Roser C. Involvement and the consistency of knowledge, attitudes, and behaviors. Communication Research. 1986;13:373–399
37. Pratt JW, Zeckhauser RJ. Principals and agents: An overview. In:  Pratt JW,  Zeckhauser RJ editor. Principals and Agents: The Structure of Business. 1985:Boston: Harvard Business School Press; 1985;p. 1–35
38. Mott DA, Schommer JC, Doucette WR, Kreling DH. Agency theory, drug formularies, and drug product selection: implications for public policy. Journal of Public Policy & Marketing. 1998;17:287–295
39. Arrow KJ. The economics of agency. In:  Pratt JW,  Zeckhauser RJ editor. Principals and Agents: The Structure of Business. Boston: Harvard Business School Press; 1985;p. 37–51
40. DeVellis RF. Scale development, theory and applications. 2nd ed. Applied Social Research Methods Series. vol. 26. Thousand Oaks, Calif: SAGE Publications; 2003;
41. Bieler GS, Williams RL. Application of the SUDAAN Software Package to Clustered Data Problems in Pharmaceutical Research. Research Triangle Park, NC: Research Triangle Institute; 1997;
42. Bryk AS, Raudenbush SW. Hierarchical Linear Models. Advanced Quantitative Techniques in the Social Sciences Series. vol. 1. Newbury Park, Calif: SAGE Publications; 1992;
43. Baron RM, Kenny DA. The moderator-mediator variable distinction in social psychological research: conceptual, strategic, and statistical considerations. Journal of Personality and Social Psychology. 1986;51:1173–1182
    • MEDLINE
    • CrossRef
44. Dillman DA. Mail and Internet Surveys. 2nd ed.. New York: John Wiley & Sons; 2000;
45. Johnson JA. Patient Satisfaction. Pharmacoeconomics and Outcomes: Applications for Patient Care. American College of Clinical Pharmacy; 1997;111–154
46. Lobo FS. Assessment of Channeling Bias and Its Impact on Interpretation of Outcomes in Observational Studies: The Case of the Cyclooxygenase-2 (COX-2) Inhibitors. Unpublished Doctoral Dissertation, University of Minnesota; 2003.
47. Dunn WN. Public Policy Analysis: An Introduction. Upper Saddle River, NJ: Prentice Hall; 2004;